Evidence map›Paper›PMID 40863823›Full record

ArticleNanomaterials (Basel, Switzerland)2025

Carborane-Containing Iron Oxide@Gold Nanoparticles for Potential Application in Neutron Capture Therapy.

Zhangali A Bekbol, Kairat A Izbasar, Alexander Zaboronok, Lana I Lissovskaya, Haolan Yang, Yuriy Pihosh, Eiichi Ishikawa, Rafael I Shakirzyanov, Ilya V Korolkov

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zhangali A BekbolThe Institute of Nuclear Physics, Ibragimov Str. 1, 050032 Almaty, Kazakhstan.
Kairat A IzbasarThe Institute of Nuclear Physics, Ibragimov Str. 1, 050032 Almaty, Kazakhstan.
Alexander ZaboronokThe Institute of Nuclear Physics, Ibragimov Str. 1, 050032 Almaty, Kazakhstan.ORCID 0000-0002-6833-9866
Lana I LissovskayaThe Institute of Nuclear Physics, Ibragimov Str. 1, 050032 Almaty, Kazakhstan.ORCID 0000-0002-3894-6366
Haolan YangDepartment of Neurosurgery, Institute of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8575, Ibaraki, Japan.ORCID 0009-0002-9842-8082
Yuriy PihoshOffice of University Professors, The University of Tokyo, 2-11-16 Yayoi, Bunkyo-ku, Tokyo 113-8656, Japan.
Eiichi IshikawaDepartment of Neurosurgery, Institute of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8575, Ibaraki, Japan.ORCID 0000-0001-9224-9767
Rafael I ShakirzyanovEngineering Profile Laboratory, L.N. Gumilyov Eurasian National University, Satpaev Str. 5, 010008 Astana, Kazakhstan.ORCID 0000-0001-9908-3034
Ilya V KorolkovThe Institute of Nuclear Physics, Ibragimov Str. 1, 050032 Almaty, Kazakhstan.ORCID 0000-0002-0766-2803

Funding

Japan Society for the Promotion of Science 23K06738Ministry of Energy of the Republic of Kazakhstan BR20081011
6 · The paper itself

Abstract

Cancer remains one of the most pressing global health challenges, driving the need for innovative treatment strategies. Boron neutron capture therapy (BNCT) offers a highly selective approach to destroying cancer cells while sparing healthy tissues. To improve boron delivery, Fe

Indexed as

carboranedrug deliveryiron oxidenanoparticlesneutron capture therapy

Identifiers

PMID40863823
PMCPMC12388822

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.